Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FWYUX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,232
Award facts
- Contract value 100% obligated
- $18,232.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $18,232.22 delivery order to AmerisourceBergen Drug Corp for the supply of Wegovy 1.7 mg/0.75 mL pen auto-injectors on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the DLA and serves as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting history demonstrates consistent capability in delivering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains through open competition. This particular delivery order for Wegovy, a glucagon-like peptide-1 receptor agonist used for weight management, exemplifies AmerisourceBergen's role in supporting federal medical procurement needs across military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FWYUX?
SPE2DB25FWYUX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FWYUX worth?
The government has obligated $18,232 on SPE2DB25FWYUX.
Is contract SPE2DB25FWYUX an order under another contract?
Yes. SPE2DB25FWYUX is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWYUX competed?
The extent of competition for SPE2DB25FWYUX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award